New England Journal of Medicine· 2014Q1· Clinical trial

A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma

Mark R. Gilbert, James J. Dignam, Terri S. Armstrong, Jeffrey S. Wefel et al.

2,804citations
Q1SCImago
2014year

Short summary

Adding bevacizumab to standard chemotherapy and radiotherapy for newly diagnosed glioblastoma did not improve overall survival, despite prolonging progression-free survival.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Genetics

GeneticsMedicine